H.R. 7006 · 117th Congress · House

INSPECTIONS Act

Active· Referred to the Subcommittee on Health.
Introduced
Mar 9, 22
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

Improving the Nation's Safe Pharmaceuticals and Excipients by Creating Tools for Inspecting and Overseeing Needed Supplies Act or the INSPECTIONS Act

This bill modifies provisions relating to the inspection of foreign drug manufacturing facilities, including by incorporating the compliance history of facilities in foreign countries into inspections and requiring periodic assessments of whether additional agreements with foreign agencies are needed. The bill also requires the Government Accountability Office to report on inspections of foreign facilities.

Action Timeline

4
  1. MAR 10, 2022Committee

    Referred to the Subcommittee on Health.

  2. MAR 09, 2022IntroReferral

    Introduced in House

  3. MAR 09, 2022IntroReferral

    Introduced in House

  4. MAR 09, 2022IntroReferral

    Referred to the House Committee on Energy and Commerce.

Committees

2

Health Subcommittee

hsif14

Referred: Mar 10, 2022

Active

Energy and Commerce Committee

hsif00

Referred: Mar 9, 2022

Active